Dergi
Flow Analysis of PDL1-Vaxx Antibody Blockade Using Magnetic Fluorescent Beads
July 07, 2023
, ,

Özet

Checkpoint inhibitors are important targets in developing therapies for the battle against cancer. This report introduces a novel PDL1 peptide-based cancer vaccine, PDL1-Vaxx, which induces neutralizing polyclonal antibody production that blocks PD-1/PDL1 complex formation. This work also details the development and testing of a fluorescent bead-based assay for analyzing this activity.